000			01845 a2200481 4500
005			20250515173402.0
264		0	_c20091211
008			200912s 0 0 eng d
022			_a1432-069X
024	7		_a10.1007/s00403-009-0967-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aColovic, Natasa
245	0	0	_aImmunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma. _h[electronic resource]
260			_bArchives of dermatological research _cOct 2009
300			_a689-92 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Murine-Derived
650	0	4	_aAntigens, Neoplasm _xmetabolism
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aImmunotherapy
650	0	4	_aInjections, Intravenous
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xdiagnosis
650	0	4	_aMale
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xmetabolism
650	0	4	_aRituximab
650	0	4	_aSkin Neoplasms _xdiagnosis
650	0	4	_aTreatment Outcome
650	0	4	_aVesicular Transport Proteins _xmetabolism
650	0	4	_aVincristine _xtherapeutic use
700	1		_aJurisic, Vladimir
700	1		_aTerzic, Tatjana
700	1		_aAtkinson, Henry Dushan
700	1		_aColovic, Milica
773	0		_tArchives of dermatological research _gvol. 301 _gno. 9 _gp. 689-92
856	4	0	_uhttps://doi.org/10.1007/s00403-009-0967-1 _zAvailable from publisher's website
999			_c18920032 _d18920032